213 related articles for article (PubMed ID: 35819634)
1. Differential spatial distribution of white matter lesions in Parkinson's and Alzheimer's diseases and cognitive sequelae.
Grey MT; Mitterová K; Gajdoš M; Uher R; Klobušiaková P; Rektorová I; Rektor I
J Neural Transm (Vienna); 2022 Aug; 129(8):1023-1030. PubMed ID: 35819634
[TBL] [Abstract][Full Text] [Related]
2. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
3. Relationships Between Lower Olfaction and Brain White Matter Lesions in Elderly Subjects with Mild Cognitive Impairment.
Heinrich J; Vidal JS; Simon A; Rigaud AS; Hanon O; Epelbaum J; Viollet C; Duron E
J Alzheimers Dis; 2018; 61(3):1133-1141. PubMed ID: 29332036
[TBL] [Abstract][Full Text] [Related]
4. The contribution of white matter lesions (WML) to Parkinson's disease cognitive impairment symptoms: A critical review of the literature.
Veselý B; Rektor I
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S166-70. PubMed ID: 26391185
[TBL] [Abstract][Full Text] [Related]
5. Cerebral white matter lesions in patients with dementia - from MCI to severe Alzheimer's disease.
Targosz-Gajniak M; Siuda J; Ochudło S; Opala G
J Neurol Sci; 2009 Aug; 283(1-2):79-82. PubMed ID: 19268974
[TBL] [Abstract][Full Text] [Related]
6. Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.
Defrancesco M; Marksteiner J; Deisenhammer E; Kemmler G; Djurdjevic T; Schocke M
J Alzheimers Dis; 2013; 34(3):665-72. PubMed ID: 23254639
[TBL] [Abstract][Full Text] [Related]
7. Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson's disease.
Stojkovic T; Stefanova E; Soldatovic I; Markovic V; Stankovic I; Petrovic I; Agosta F; Galantucci S; Filippi M; Kostic V
J Neurol; 2018 Jun; 265(6):1320-1327. PubMed ID: 29572571
[TBL] [Abstract][Full Text] [Related]
8. Clinical correlates of white matter lesions in Parkinson's disease using automated multi-modal segmentation measures.
Fang E; Fartaria MJ; Ann CN; Maréchal B; Kober T; Lim JX; Ooi LQR; Chen C; Lim SL; Tan EK; Chan LL
J Neurol Sci; 2021 Aug; 427():117518. PubMed ID: 34118693
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent cognitive and affective differences in Alzheimer's and Parkinson's diseases in relation to MRI findings.
Tokuchi R; Hishikawa N; Sato K; Hatanaka N; Fukui Y; Takemoto M; Ohta Y; Yamashita T; Abe K
J Neurol Sci; 2016 Jun; 365():3-8. PubMed ID: 27206864
[TBL] [Abstract][Full Text] [Related]
10. The impact of white matter lesions on the cognitive outcome of subthalamic nucleus deep brain stimulation in Parkinson's disease.
Blume J; Lange M; Rothenfusser E; Doenitz C; Bogdahn U; Brawanski A; Schlaier J
Clin Neurol Neurosurg; 2017 Aug; 159():87-92. PubMed ID: 28582689
[TBL] [Abstract][Full Text] [Related]
11. Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer's disease.
Vipin A; Loke YM; Liu S; Hilal S; Shim HY; Xu X; Tan BY; Venketasubramanian N; Chen CL; Zhou J
Alzheimers Res Ther; 2018 Aug; 10(1):82. PubMed ID: 30121086
[TBL] [Abstract][Full Text] [Related]
12. Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment.
Hirao K; Yamashita F; Tsugawa A; Haime R; Fukasawa R; Sato T; Kanetaka H; Umahara T; Sakurai H; Hanyu H; Shimizu S
J Alzheimers Dis; 2021; 80(2):877-883. PubMed ID: 33579856
[TBL] [Abstract][Full Text] [Related]
13. Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease.
Charissé D; Erus G; Pomponio R; Gorges M; Schmidt N; Schneider C; Liepelt-Scarfone I; Riedel O; Reetz K; Schulz JB; Berg D; Storch A; Witt K; Dodel R; Kalbe E; Kassubek J; Hilker-Roggendorf R; Baudrexel S
Neurobiol Aging; 2022 Jan; 109():31-42. PubMed ID: 34649002
[TBL] [Abstract][Full Text] [Related]
14. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
[TBL] [Abstract][Full Text] [Related]
15. White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia.
Dadar M; Manera AL; Ducharme S; Collins DL
Neurobiol Aging; 2022 Mar; 111():54-63. PubMed ID: 34968832
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.
Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH
Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368
[TBL] [Abstract][Full Text] [Related]
17. Retinal Nerve Fiber Layer Thinning in Alzheimer's Disease: A Case-Control Study in Comparison to Normal Aging, Parkinson's Disease, and Non-Alzheimer's Dementia.
Pillai JA; Bermel R; Bonner-Jackson A; Rae-Grant A; Fernandez H; Bena J; Jones SE; Ehlers JP; Leverenz JB
Am J Alzheimers Dis Other Demen; 2016 Aug; 31(5):430-6. PubMed ID: 26888864
[TBL] [Abstract][Full Text] [Related]
18. Amnestic mild cognitive impairment in Parkinson's disease: White matter structural changes and mechanisms.
Chen F; Wu T; Luo Y; Li Z; Guan Q; Meng X; Tao W; Zhang H
PLoS One; 2019; 14(12):e0226175. PubMed ID: 31830080
[TBL] [Abstract][Full Text] [Related]
19. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
[TBL] [Abstract][Full Text] [Related]
20. White matter lesions and the cholinergic deficit in aging and mild cognitive impairment.
Richter N; Michel A; Onur OA; Kracht L; Dietlein M; Tittgemeyer M; Neumaier B; Fink GR; Kukolja J
Neurobiol Aging; 2017 May; 53():27-35. PubMed ID: 28208063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
